Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Kadimastem Ltd. logo — A clinical stage biotech company using PLATFORM TECH for the...

Kadimastem Ltd.

A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments

Founded 2009 Israel Israel 32 employees Grant Total: $51.65M Biotechnology, Health and Wellness

General Information

Company Name Kadimastem Ltd.
Founded Year 2009
Location Israel Israel
Founders / Decision Makers
Team member
Employees 32
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Kadimastem Ltd.. To contact Kadimastem Ltd., visit kadimastem.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Kadimastem Ltd. compare?

A PDF of Kadimastem Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Kadimastem Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Kadimastem Ltd.

Kadimastem Ltd. is a clinical stage biotech company that has been disrupting the industry since its establishment in 2009. The company's slogan "A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments" embodies its commitment to leveraging cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, and Bio-Banking of functional human cells to provide OFF-THE-SHELF TREATMENT for multiple indications, with a focus on addressing ALS and Type 1 Diabetes. Kadimastem, listed as TASE:KDST, is headquartered in Israel. The company's recent milestone includes receiving a grant investment from the BIRD Foundation on 19 January 2023. This investment signifies external validation and support for Kadimastem's innovative approach and potential in the biotechnology space. With a focus on pioneering treatments for debilitating diseases, Kadimastem is poised to make significant strides in the biotech sector, positioning itself as a promising opportunity for venture capital consideration.

Business keywords: Biotech, Stem Cell Therapy, Regenerative Medicine, Neurodegenerative Disorders, Cell Manufacturing, Drug Screening, High Content Screening, Cell-based Therapeutics, GMP Facilities, Type 1 Diabetes, ALS Treatment, Clinical Trials, Diabetes Cure, Israel, Bio-banking

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
BIRD Foundation
BIRD Foundation
19 Jan 2023
Post IPO Equity ILS10.00M 1
Ilex Medical
Ilex Medical
25 Nov 2021
Post IPO Equity $5.00M 4
Michel Revel, Julien Ruggieri +2
26 Oct 2021
Post IPO Equity $5.15M 1
Altshuler Shaham
Altshuler Shaham
02 Oct 2018
Post IPO Equity ILS15.60M -
01 Dec 2017
Post IPO Equity ILS7.20M -
01 Feb 2017
Post IPO Equity ILS4.00M -
01 Jul 2016
Post IPO Equity ILS4.70M -
01 Dec 2015

Kadimastem Ltd. Alternatives & Competitors

View All Alternatives
Kadimastem Ltd. vs
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics Israel

BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenera...

Post-IPO Equity
36 employees
Biotechnology, Health Care
Compare Kadimastem Ltd. vs Brainstorm Cell Therapeutics
Kadimastem Ltd. vs
ViaCyte
ViaCyte United States

Regenerating Health: Transforming the lives of patients with insulin-requiring diabetes

Series D
35 employees
Biotechnology, Health Care
Compare Kadimastem Ltd. vs ViaCyte
Kadimastem Ltd. vs
Celltex Therapeutics Corporation
Celltex Therapeutics Corporation United States

A Houston-based biotech company focused on breakthroughs using autologous, adipose-derived Mesenchym...

Venture round
33 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Kadimastem Ltd.

A clinical stage biotech company using PLATFORM TECH for the Manufacturing of cells for ALS and Diabetes treatments
Kadimastem Ltd. was founded in 2009.
Kadimastem Ltd. is headquartered in Israel.
Kadimastem Ltd. operates in Biotechnology and Health and Wellness. Its work centres on Biotech, Stem Cell Therapy, Regenerative Medicine and Neurodegenerative Disorders.
Kadimastem Ltd. has approximately 32 employees.
Kadimastem Ltd. has completed 8 funding rounds, raising a total of $51.65M. The latest funding stage is Grant.
Top alternatives and competitors to Kadimastem Ltd. include Brainstorm Cell Therapeutics, ViaCyte, Celltex Therapeutics Corporation, Aspen Neuroscience, Inc., NeuroSense Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kadimastem Ltd. and Brainstorm Cell Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kadimastem Ltd., https://bouncewatch.com/company/kadimastem-ltd, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout